Paediatric visceral leishmaniasis: a retrospective study on clinical manifestations,demographic features and laboratory findings of hospitalised cases in Iran between 2006 and 2016
Restricted accessBrief reportFirst published online January, 2019
Paediatric visceral leishmaniasis: a retrospective study on clinical manifestations,demographic features and laboratory findings of hospitalised cases in Iran between 2006 and 2016
Visceral leishmaniasis (VL) is a neglected disease. Our retrospective study describes 38 clinical and epidemiological characteristics of VL in patients admitted to a paediatric hospital in Tehran, Iran, who came from different geographical regions, indicating that the disease has spread to most parts of the country. Some 76.3% of the children documented suffered with symptoms of the disease for two months before admission.
AlvarJVelezIDBernCet al.Leishmaniasis worldwide and global estimates of its incidence. PLoS One2012; 7: e35671–e35671.
2.
Tofighi NaeemAMahmoudiSSabouiFet al.Clinical features and laboratory findings of visceral leishmaniasis in children referred to Children Medical Center Hospital, Tehran, Iran during 2004–2011. Iran J Parasitol2014; 9: 1–5.
3.
World Health Organization. Control of leishmaniases. Technical report series 949. Geneva: WHO, 2010.
4.
HeidariAMohebaliMKabirKet al.Visceral leishmaniasis in rural areas of Alborz province of Iran and implication to health policy. Korean J Parasitol2015; 53: 379–383.
5.
World Health Organization. Manual on visceral leishmaniasis control, Geneva: WHO, 1996.
6.
SarkariBNarakiTGhateeMAet al.Visceral leishmaniasis in Southwestern Iran: a retrospective clinico-hematological analysis of 380 consecutive hospitalized cases (1999–2014). PLoS One2016; 11: e0150406–e0150406.
7.
MiaoRWangZGuoQet al.Clinical and epidemiologic features of visceral leishmaniasis in children in southwestern China: a retrospective analysis from 2001 to 2015. Pediatr Infect Dis J2017; 36: 9–12.
8.
SayiliAOzkanATSchalligHD. Pediatric visceral leishmaniasis caused by Leishmania infantum in northern Cyprus. Am J Trop Med Hyg2016; 95: 1386–1388.
9.
BokaieSSharifiLMamishiSet al.A case series study on clinical and epidemiologic aspects of Kala azar in patients referred to the Children’s Medical Center since 1991 to 2003. Iran J Epidemiol2006; 1: 21–26.
10.
MohammadiKKMohebaliMMamishiSet al.Epidemiological characteristics of Kala-azar in hospitalized patients in Ardebil province [in Persian]. J Sch Public Health Inst Public Health Res2003; 6: 11–24.
11.
BaratiMDaie PariziMHSharifiI. Epidemiological and Clinical aspects of kala-azar in hospitalized children of Kerman province, during 1991-2006. J Kerman Univ Med Sci2008; 15: 148–155.
12.
Al-GhazalyJAl-DubaiWAbdullahMet al.Hematological characteristics of Yemeni adults and children with visceral leishmaniasis. could eosinopenia be a suspicion index?Mediterr J Hematol Infect Dis2017; 9: e2017056–e2017056.
13.
AissiWBenHKHabboulZet al.Epidemiological, clinical and biological features of infantile visceral leishmaniasis at Kairouan hospital (Tunisia): about 240 cases. Bull Soc Pathol Exot2015; 108: 265–271.
14.
Naufal SpirPRPrestes-CarneiroLEFonsecaESet al.Clinical characteristics and spatial distribution of visceral leishmaniasis in children in São Paulo state: an emerging focus of visceral leishmaniasis in Brazil. Pathog Glob Health2017; 111: 91–97.
